Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.

Seibel NL, Shad AT, Bekersky I, Groll AH, Gonzalez C, Wood LV, Jarosinski P, Buell D, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01477-16. doi: 10.1128/AAC.01477-16. Print 2017 Feb.

2.

Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case report.

Shad AT, Huo JS, Darcy C, Abu-Ghosh A, Esposito G, Holuba MJ, Robey N, Cooke KR, Symons HJ, Chen AR, Llosa NJ.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26257. Epub 2016 Sep 21.

PMID:
27650634
3.

Validation of a milk consumption stage of change algorithm among adolescent survivors of childhood cancer.

Mays D, Gerfen E, Mosher RB, Shad AT, Tercyak KP.

J Nutr Educ Behav. 2012 Sep-Oct;44(5):464-8. doi: 10.1016/j.jneb.2012.04.005. Epub 2012 Jul 4.

4.

Pediatric palliative care and eHealth opportunities for patient-centered care.

Madhavan S, Sanders AE, Chou WY, Shuster A, Boone KW, Dente MA, Shad AT, Hesse BW.

Am J Prev Med. 2011 May;40(5 Suppl 2):S208-16. doi: 10.1016/j.amepre.2011.01.013.

5.

Survey of consumer informatics for palliation and hospice care.

Corn M, Gustafson DH, Harris LM, Kutner JS, McFarren AE, Shad AT.

Am J Prev Med. 2011 May;40(5 Suppl 2):S173-8. doi: 10.1016/j.amepre.2011.01.015.

6.

Improving short-term sun safety practices among adolescent survivors of childhood cancer: a randomized controlled efficacy trial.

Mays D, Black JD, Mosher RB, Shad AT, Tercyak KP.

J Cancer Surviv. 2011 Sep;5(3):247-54. doi: 10.1007/s11764-011-0177-7. Epub 2011 Feb 27.

7.

Efficacy of the Survivor Health and Resilience Education (SHARE) program to improve bone health behaviors among adolescent survivors of childhood cancer.

Mays D, Black JD, Mosher RB, Heinly A, Shad AT, Tercyak KP.

Ann Behav Med. 2011 Aug;42(1):91-8. doi: 10.1007/s12160-011-9261-5.

8.

Development and evaluation of an educational interactive CD-ROM for teens with cancer.

Jones JK, Kamani SA, Bush PJ, Hennessy KA, Marfatia A, Shad AT.

Pediatr Blood Cancer. 2010 Sep;55(3):512-9. doi: 10.1002/pbc.22608.

9.

Pediatric acute lymphoblastic leukemia and exposure to pesticides.

Soldin OP, Nsouli-Maktabi H, Genkinger JM, Loffredo CA, Ortega-Garcia JA, Colantino D, Barr DB, Luban NL, Shad AT, Nelson D.

Ther Drug Monit. 2009 Aug;31(4):495-501. doi: 10.1097/FTD.0b013e3181aae982. Erratum in: Ther Drug Monit. 2009 Oct;31(5):668. Nsouly-Maktabi, Hala [corrected to Nsouli-Maktabi, Hala].

10.

Aggressive central giant cell lesion of the maxilla: surgical management and the use of adjuvant interferon alfa-2a.

Baker SB, Parikh PM, Rhodes DN, Abu-Ghosh A, Shad AT.

Plast Reconstr Surg. 2008 Aug;122(2):77e-9e. doi: 10.1097/PRS.0b013e31817d5f3d. No abstract available.

PMID:
18626327
11.

NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea.

Liebelt EL, Balk SJ, Faber W, Fisher JW, Hughes CL, Lanzkron SM, Lewis KM, Marchetti F, Mehendale HM, Rogers JM, Shad AT, Skalko RG, Stanek EJ.

Birth Defects Res B Dev Reprod Toxicol. 2007 Aug;80(4):259-366. No abstract available.

PMID:
17712860
12.

Multiple behavioral risk factors among adolescent survivors of childhood cancer in the Survivor Health and Resilience Education (SHARE) program.

Tercyak KP, Donze JR, Prahlad S, Mosher RB, Shad AT.

Pediatr Blood Cancer. 2006 Nov;47(6):825-30.

PMID:
16333821
13.

Treatment of immune thrombocytopenic purpura in children : current concepts.

Shad AT, Gonzalez CE, Sandler SG.

Paediatr Drugs. 2005;7(5):325-36. Review.

PMID:
16220997
15.

Brief report: health beliefs among survivors of childhood cancer.

Tercyak KP, Nicolas M, Councill T, Prahlad S, Taylor KL, Shad AT.

J Pediatr Psychol. 2004 Jul-Aug;29(5):397-402.

PMID:
15187178
16.

Comparison of intermittent versus continuous infusion of propofol for elective oncology procedures in children.

Klein SM, Hauser GJ, Anderson BD, Shad AT, Gootenberg JE, Dalton HJ, Hertzog JH.

Pediatr Crit Care Med. 2003 Jan;4(1):78-82.

PMID:
12656549
17.

Prospective evaluation of propofol anesthesia in the pediatric intensive care unit for elective oncology procedures in ambulatory and hospitalized children.

Hertzog JH, Dalton HJ, Anderson BD, Shad AT, Gootenberg JE, Hauser GJ.

Pediatrics. 2000 Oct;106(4):742-7.

PMID:
11015517
18.

Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD).

Anderson B, Shad AT, Gootenberg JE, Sandler SG.

Am J Hematol. 1999 Mar;60(3):245-7.

19.

Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.

Ozdemirli M, Fanburg-Smith JC, Hartmann DP, Shad AT, Lage JM, Magrath IT, Azumi N, Harris NL, Cossman J, Jaffe ES.

Am J Surg Pathol. 1998 Jul;22(7):795-804. Review.

PMID:
9669342
20.

Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas.

Haddy TB, Adde MA, McCalla J, Domanski MJ, Datiles M 3rd, Meehan SC, Pikus A, Shad AT, Valdez I, Lopez Vivino L, Magrath IT.

J Clin Oncol. 1998 Jun;16(6):2070-9.

PMID:
9626206
21.

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

Weintraub M, Adde MA, Venzon DJ, Shad AT, Horak ID, Neely JE, Seibel NL, Gootenberg J, Arndt C, Nieder ML, Magrath IT.

J Clin Oncol. 1996 Mar;14(3):935-40.

PMID:
8622042
22.

Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection.

Izraeli S, Mueller BU, Ling A, Temeck BK, Lewis LL, Chang R, Shad AT, Pass HI, Pizzo PA.

Pediatr Infect Dis J. 1996 Feb;15(2):112-6.

PMID:
8822282
23.

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, et al.

N Engl J Med. 1995 Jan 19;332(3):143-9.

24.

Lymphocyte depletion during treatment with intensive chemotherapy for cancer.

Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE.

Blood. 1994 Oct 1;84(7):2221-8.

Supplemental Content

Support Center